Celastrol nanoparticles inhibit corneal neovascularization induced by suturing in rats

References

• CursiefenCCaoJChenLInhibition of hemangiogenesis and lymphangiogenesis after normal-risk corneal transplantation by neutralizing VEGF promotes graft survivalInvest Ophthalmol Vis Sci20044582666267315277490
   PubMed Web of Science ®Google Scholar
• BauerDMrzykSvan RooijenNSteuhlKPHeiligenhausAMacrophage-depletion influences the course of murine HSV-1 keratitisCurr Eye Res2000201455310611714
   PubMed Web of Science ®Google Scholar
• StrombladSChereshDAIntegrins, angiogenesis and vascular cell survivalChem Biol19963118818858939711
   PubMed Web of Science ®Google Scholar
• LeeHSChungSKThe effect of subconjunctival suramin on corneal neovascularization in rabbitsCornea2010291869219907290
   PubMed Web of Science ®Google Scholar
• BernardiniGRibattiDSpinettiGAnalysis of the role of chemokines in angiogenesisJ Immunol Methods20032731–28310112535800
   PubMed Web of Science ®Google Scholar
• StrieterRMBurdickMDGompertsBNBelperioJAKeaneMPCXC chemokines in angiogenesisCytokine Growth Factor Rev200516659360916046180
   PubMed Web of Science ®Google Scholar
• David DongZMAplinACNicosiaRFRegulation of angiogenesis by macrophages, dendritic cells, and circulating myelomonocytic cellsCurr Pharm Des200915436537919199964
   PubMed Web of Science ®Google Scholar
• SinghBLucciARole of cyclooxygenase-2 in breast cancerJ Surg Res2002108117317912472107
   PubMed Web of Science ®Google Scholar
• SzekaneczZKochAEMacrophages and their products in rheumatoid arthritisCurr Opin Rheumatol200719328929517414958
   PubMed Web of Science ®Google Scholar
• GabrusiewiczKEllert-MiklaszewskaALipkoMSielskaMFrankowskaMKaminskaBCharacteristics of the alternative phenotype of microglia/macrophages and its modulation in experimental gliomasPLoS One201168e2390221901144
   PubMed Web of Science ®Google Scholar
• UsuiTYamagamiSKishimotoSSeiichYNakayamaTAmanoSRole of macrophage migration inhibitory factor in corneal neovascularizationInvest Ophthalmol Vis Sci20074883545355017652722
   PubMed Web of Science ®Google Scholar
• KannaiyanRShanmugamMKSethiGMolecular targets of celastrol derived from Thunder of God Vine: potential role in the treatment of inflammatory disorders and cancerCancer Lett2011303192021168266
   PubMed Web of Science ®Google Scholar
• HuangLZhangZZhangSInhibitory action of celastrol on hypoxia-mediated angiogenesis and metastasis via the HIF-1α pathwayInt J Mol Med201127340741521249310
   PubMed Web of Science ®Google Scholar
• SethiGAhnKSPandeyMKAggarwalBBCelastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activationBlood200710972727273517110449
   PubMed Web of Science ®Google Scholar
• HuangYZhouYFanYZhouDCelastrol inhibits the growth of human glioma xenografts in nude mice through suppressing VEGFR expressionCancer Lett2008264110110618343027
   PubMed Web of Science ®Google Scholar
• AllisonACCacabelosRLombardiVRAlvarezXAVigoCCelastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer’s diseaseProg Neuropsychopharmacol Biol Psychiatry20012571341135711513350
   PubMed Web of Science ®Google Scholar
• HuangFCChanWKMoriartyKJNovel cytokine release inhibitors. Part I: triterpenesBioorg Med Chem Lett1998814188318869873452
   PubMed Web of Science ®Google Scholar
• KimYKimKLeeHCelastrol binds to ERK and inhibits FcepsilonRI signaling to exert an anti-allergic effectEur J Pharmacol20096121–313114219356729
   PubMed Web of Science ®Google Scholar
• JinHZHwangBYKimHSLeeJHKimYHLeeJJAnti-inflammatory constituents of Celastrus orbiculatus inhibit the NF-kappaB activation and NO productionJ Nat Prod2002651899111809076
   PubMed Web of Science ®Google Scholar
• XiongMPYanezJARemsbergCMFormulation of a geldana-mycin prodrug in mPEG-b-PCL micelles greatly enhances tolerability and pharmacokinetics in ratsJ Control Release20081291334018456363
   PubMed Web of Science ®Google Scholar
• MikhailASAllenCPoly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles containing chemically conjugated and physically entrapped docetaxel: synthesis, characterization, and the influence of the drug on micelle morphologyBiomacromolecules20101151273128020369884
   PubMed Web of Science ®Google Scholar
• HseuYCChenSCLinWHToona sinensis (leaf extracts) inhibit vascular endothelial growth factor (VEGF)-induced angiogenesis in vascular endothelial cellsJ Ethnopharmacol2011134111112121130856
   PubMed Web of Science ®Google Scholar
• PangXYiZZhangJCelastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathwayCancer Res20107051951195920160026
   PubMed Web of Science ®Google Scholar
• LvWChenLZhouDHWeiBInfluence of specific blocking of the delta-like ligand 4/notch signal transduction pathway on the biological behavior of human umbilical vein endothelial cellsCancer Biother Radiopharm201025444945420701540
   PubMed Web of Science ®Google Scholar
• YoonSCKimJKKwakDHAntitumor activity of Soamsan, a traditional Korean medicine, via suppressing angiogenesis and growth factor transcriptionJ Ethnopharmacol2004932–340340815234785
   PubMed Web of Science ®Google Scholar
• Perez-SantonjaJJCampos-MolloELledo-RiquelmeMJavaloyJAlioJLInhibition of corneal neovascularization by topical bevaci-zumab (anti-VEGF) and sunitinib (anti-VEGF and anti-PDGF) in an animal modelAm J Ophthalmol20101504519528e120591397
   PubMed Web of Science ®Google Scholar
• YorkMSteilingWA critical review of the assessment of eye irritation potential using the Draize rabbit eye testJ Appl Toxicol19981842332409719422
   PubMed Web of Science ®Google Scholar
• SuWLiZLinMThe effect of doxycycline temperaturesensitive hydrogel on inhibiting the corneal neovascularization induced by BFGF in ratsGraefes Arch Clin Exp Ophthalmol2011249342142720953876
   PubMed Web of Science ®Google Scholar
• JiaCZhuWRenSXiHLiSWangYComparison of genome-wide gene expression in suture- and alkali burn-induced murine corneal neovascularizationMol Vis2011172386239921921991
   PubMed Web of Science ®Google Scholar
• SereginVVCofferJLBiomineralization of calcium disilicide in porous polycaprolactone scaffoldsBiomaterials200627274745475416740307
   PubMed Web of Science ®Google Scholar
• MondrinosMJDembzynskiRLuLPorogen-based solid free-form fabrication of polycaprolactone-calcium phosphate scaffolds for tissue engineeringBiomaterials200627254399440816678255
   PubMed Web of Science ®Google Scholar
• MoonHTLeeYKHanJKByunYImproved blood compatibility by sustained release of heparin-deoxycholic acid conjugates in a PCL-PEG multiblock copolymer matrixJ Biomater Sci Polym Ed200213781782812296446
   PubMed Web of Science ®Google Scholar
• HuangMHLiSHutmacherDWDegradation and cell culture studies on block copolymers prepared by ring opening polymerization of epsilon-caprolactone in the presence of poly(ethylene glycol)J Biomed Mater Res A200469341742715127388
   PubMed Web of Science ®Google Scholar
• WeiXGongCGouMBiodegradable poly(epsilon-caprolactone)-poly(ethylene glycol) copolymers as drug delivery systemInt J Pharm2009381111819664700
   PubMed Web of Science ®Google Scholar
• YanezJAForrestMLOhgamiYKwonGSDaviesNMPharmacometrics and delivery of novel nanoformulated PEGb-poly(epsilon-caprolactone) micelles of rapamycinCancer Chemother Pharmacol200861113314417393166
   PubMed Web of Science ®Google Scholar
• ForrestMLZhaoAWonCYMalickAWKwonGSLipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micellesJ Control Release2006116213914916926059
   PubMed Web of Science ®Google Scholar
• ShuaiXAiHNasongklaNKimSGaoJMicellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin deliveryJ Control Release200498341542615312997
   PubMed Web of Science ®Google Scholar
• YinHGongCShiSLiuXWeiYQianZToxicity evaluation of biodegradable and thermosensitive PEG-PCL-PEG hydrogel as a potential in situ sustained ophthalmic drug delivery systemJ Biomed Mater Res B Appl Biomater201092112913719802831
   PubMed Web of Science ®Google Scholar
• SamolovBSteenBSeregardSvan der PloegIMontanPKvantaADelayed inflammation-associated corneal neovascularization in MMP-2-deficient miceExp Eye Res200580215916615670794
   PubMed Web of Science ®Google Scholar
• JinYAritaMZhangQAnti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediatorsInvest Ophthalmol Vis Sci200950104743475219407006
   PubMed Web of Science ®Google Scholar
• SeoWYJuSMSongHYCelastrol suppresses IFN-gamma-induced ICAM-1 expression and subsequent monocyte adhesiveness via the induction of heme oxygenase-1 in the HaCaT cellsBiochem Biophys Res Commun2010398114014520599745
   PubMed Web of Science ®Google Scholar
• KochAEPolveriniPJKunkelSLInterleukin-8 as a macrophagederived mediator of angiogenesisScience19922585089179818011281554
   PubMed Web of Science ®Google Scholar
• KogaMKaiHEgamiKMutant MCP-1 therapy inhibits tumor angiogenesis and growth of malignant melanoma in miceBiochem Biophys Res Commun2008365227928417991428
   PubMed Web of Science ®Google Scholar
• HoHHAntonivTTJiJDIvashkivLBLipopolysaccharide-induced expression of matrix metalloproteinases in human monocytes is suppressed by IFN-gamma via superinduction of ATF-3 and suppression of AP-1J Immunol200818175089509718802113
   PubMed Web of Science ®Google Scholar
• GilleJSwerlickRACaughmanSWTransforming growth factoralpha- induced transcriptional activation of the vascular permeability factor (VPF/VEGF) gene requires AP-2-dependent DNA binding and transactivationEMBO J19971647507599049304
   PubMed Web of Science ®Google Scholar
• MalemudCJGrowth hormone, VEGF and FGF: involvement in rheumatoid arthritisClin Chim Acta20073751–2101916893535
   PubMed Web of Science ®Google Scholar
• WangSLiuHRenLPanYZhangYInhibiting colorectal carcinoma growth and metastasis by blocking the expression of VEGF using RNA interferenceNeoplasia200810439940718392139
   PubMed Web of Science ®Google Scholar
• LohelaMBryMTammelaTAlitaloKVEGFs and receptors involved in angiogenesis versus lymphangiogenesisCurr Opin Cell Biol200921215416519230644
   PubMed Web of Science ®Google Scholar
• SkotnickiJSZaskANelsonFCAlbrightJDLevinJIDesign and synthetic considerations of matrix metalloproteinase inhibitorsAnn N Y Acad Sci1999878617210415720
   PubMed Web of Science ®Google Scholar
• ThornsVWalterGFThornsCExpression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomasAnticancer Res2003235A3937394414666700
   PubMed Web of Science ®Google Scholar
• MuroskiMERoycikMDNewcomerRGMatrix metalloproteinase- 9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosisCurr Pharm Biotechnol200891344618289055
   PubMed Web of Science ®Google Scholar
• KimYKangHJangSWKoJCelastrol inhibits breast cancer cell invasion via suppression of NF-κB-mediated matrix metalloproteinase-9 expressionCell Physiol Biochem201128217518421865725
   PubMedGoogle Scholar
• KimDHShinEKKimYHSuppression of inflammatory responses by celastrol, a quinone methide triterpenoid isolated from Celastrus regeliiEur J Clin Invest200939981982719549173
   PubMed Web of Science ®Google Scholar
• JungHWChungYSKimYSParkYKCelastrol inhibits production of nitric oxide and proinflammatory cytokines through MAPK signal transduction and NF-kappaB in LPS-stimulated BV-2 microglial cellsExp Mol Med200739671572118160842
   PubMed Web of Science ®Google Scholar